SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-17-010199
Filing Date
2017-09-05
Accepted
2017-09-05 06:17:58
Documents
11
Period of Report
2017-09-05

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1598
2 ex24-1.htm EX-24.1 7650
3 image_004.jpg GRAPHIC 870991
4 image_005.jpg GRAPHIC 1059346
5 image_006.jpg GRAPHIC 1076054
6 image_007.jpg GRAPHIC 1099390
7 image_008.jpg GRAPHIC 974815
8 image_009.jpg GRAPHIC 1014510
9 image_010.jpg GRAPHIC 1032609
10 image_011.jpg GRAPHIC 675060
11 image_012.jpg GRAPHIC 333876
  Complete submission text file 0001493152-17-010199.txt   11213140
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121 (858) 210-7333
ONCOSEC MEDICAL Inc (Issuer) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARDELYX, INC. 34715 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555
Business Address
Jenkins Annalisa (Reporting) CIK: 0001639481 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54318 | Film No.: 171067357